Abstract

Hepatic hemangiomas (HHs) are the most common type of benign liver tumor, with an incidence of ~3–20 % [1]. Among the different pathological types of HH, cavernous hemangioma is most commonly seen in clinics, and tumors are often discovered by ultrasound or contrast-enhanced CT in physical examinations. The majority of HH patients have no clinical symptoms, but some suffer from upper abdominal pain and discomfort. Although surgical resection is often adopted for the treatment of HHs, there are still no uniform standards in terms of surgical indications. Other treatment methods include radiofrequency ablation, hepatic artery embolization, suture and ligation, hepatic artery ligation, and microwave coagulation. For a small number of patients with diffuse HHs or unresectable giant HHs, liver transplantation can be performed if liver decompensation occurs.

Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.